In this work, we sought to determine whether a modified form of CXCL12, CXCL12(P2G), which acts as an antagonist of CXCR4 [11], is able to block metastasis in the 4T1.2 orthotopic mouse model of breast cancer. Here, CXCL12 is linked to breast cancer.